Overview
Miami-based Openevidence has secured a $250 million Series D funding round, doubling its valuation to $12 billion. The funding, co-led by Thrive Capital and DST Global, aims to enhance its AI platform, which provides evidence-based medical answers to clinicians. With over 10,000 hospitals using the tool, Openevidence reported $100 million in annual revenue and a 30% month-on-month growth, highlighting its critical role in improving patient care.
Products
Loading...
Recent Deals
Investors: Thrive Capital, DST Global
Miami-based Openevidence has secured a $250 million Series D funding round, doubling its valuation to $12 billion. The funding, co-led by Thrive Capital and DST Global, aims to enhance its AI platform, which provides evidence-based medical answers to clinicians. With over 10,000 hospitals using the tool, Openevidence reported $100 million in annual revenue and a 30% month-on-month growth, highlighting its critical role in improving patient care.